REGN
$805.60-0.23%
as of close, Oct 21, 2026
☾ AH $805.60 -0.23%
REGN financial statements
The full income statement, balance sheet, and cash-flow statement for Regeneron Pharmaceuticals Inc. (REGN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 110.2M2024-09 109.9M2024-12 109.3M2025-03 108.0M2025-06 106.0M2025-09 105.1M2025-12 105.7M2026-03 104.8M2026-06 103.0M-6.6% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 14.3B+1.0% | 14.2B+8.3% | 13.1B+7.8% | 12.2B-24.3% | 16.1B+89.1% | |
| Research & development | 5.85B+14.0% | 5.13B+15.6% | 4.44B+23.6% | 3.59B+25.6% | 2.86B+8.1% | |
| Selling, general & administrative | 2.70B-8.6% | 2.95B+12.3% | 2.63B+24.4% | 2.12B+15.9% | 1.82B+35.6% | |
| Amortization of intangibles | 179M+38.7% | 129M+39.8% | 92.2M+145.2% | 37.6M | 0.00 | |
| Provision for credit losses | — | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating income | 3.58B-10.3% | 3.99B-1.4% | 4.05B-14.6% | 4.74B-47.0% | 8.95B+150.1% | |
| Interest expense | 43.8M-20.7% | 55.2M-24.4% | 73.0M+22.9% | 59.4M+3.7% | 57.3M+0.7% | |
| Other non-operating income | 1.70B+100.9% | 844M+275.0% | 225M+25.6% | 179M-58.9% | 436M+50.1% | |
| Gain (loss) on equity securities | 956M+711.9% | 118M+150.0% | -236M-492.0% | -39.8M-110.3% | 386M+97.0% | |
| Pre-tax income | 5.23B+9.4% | 4.78B+13.8% | 4.20B-13.6% | 4.86B-47.9% | 9.33B+144.7% | |
| Income tax | 726M+97.6% | 367M+49.5% | 246M-52.8% | 520M-58.4% | 1.25B+320.8% | |
| Net income | 4.50B+2.1% | 4.41B+11.6% | 3.95B-8.9% | 4.34B-46.3% | 8.08B+129.9% | |
| $41.48+8.2% | $38.34+10.3% | $34.77-9.0% | $38.22-46.9% | $71.97+135.8% | ||
| EPS (basic) | $43.07+5.3% | $40.90+10.4% | $37.05-8.5% | $40.51-47.0% | $76.40+134.0% | |
| Weighted-avg shares (basic) | 105M-3.1% | 108M+1.1% | 107M-0.4% | 107M+1.3% | 106M-1.8% | |
| Weighted-avg shares (diluted) | 109M-5.6% | 115M+1.2% | 114M+0.2% | 114M+1.2% | 112M-2.5% | |
| Dividends per share | $3.41 | — | — | — | — | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 18.0B-3.4% | 18.7B-4.2% | 19.5B+22.6% | 15.9B+13.3% | 14.0B+43.3% | ||
| Cash & equivalents | 3.12B+25.3% | 2.49B-8.9% | 2.73B-12.1% | 3.11B+7.6% | 2.89B+31.5% | |
| Short-term investments | 5.49B-15.9% | 6.52B-19.6% | 8.11B+75.0% | 4.64B+65.0% | 2.81B+101.6% | |
| Accounts receivable | 5.74B-7.6% | 6.21B+9.6% | 5.67B+6.4% | 5.33B-11.7% | 6.04B+46.7% | |
| Inventory | 3.20B+3.7% | 3.09B+19.6% | 2.58B+7.4% | 2.40B+23.1% | 1.95B+1.8% | |
| Prepaid expenses | 475M+36.0% | 349M-9.7% | 387M-6.0% | 411M+23.7% | 332M+106.7% | |
| 40.6B+7.4% | 37.8B+14.1% | 33.1B+13.2% | 29.2B+14.9% | 25.4B+48.2% | ||
| Property, plant & equipment | — | — | — | — | 3.48B+8.1% | |
| Operating lease right-of-use | 246M+13.1% | 217M+178.7% | 78.0M+9.6% | 71.2M | — | |
| Intangible assets | 1.26B+9.5% | 1.15B+10.6% | 1.04B+13.4% | 916M+13564.2% | 6.70M | |
| Long-term investments | 10.3B+15.3% | 8.90B+64.9% | 5.40B-18.1% | 6.59B-3.6% | 6.84B+118.1% | |
| Deferred tax assets | 4.08B+23.0% | 3.31B+28.7% | 2.58B+49.4% | 1.72B+96.6% | 877M+2.1% | |
| Other non-current assets | 1.82B+60.3% | 1.14B+155.8% | 444M+32.0% | 336M+55.7% | 216M+28.6% | |
| 4.37B+10.8% | 3.94B+15.2% | 3.42B+9.0% | 3.14B-20.1% | 3.93B+45.8% | ||
| Accounts payable | 939M+18.9% | 790M+30.2% | 607M+3.0% | 589M+4.5% | 564M+18.6% | |
| Accrued liabilities | 2.88B+13.8% | 2.53B+7.2% | 2.36B+13.7% | 2.07B-6.0% | 2.21B+34.2% | |
| Deferred revenue | 553M-11.9% | 628M+36.8% | 459M-4.0% | 478M+8.1% | 442M-23.5% | |
| Current lease liability | 37.8M+24.8% | 30.3M+59.5% | 19.0M+53.2% | 12.4M | — | |
| Finance lease liability (current) | 0.00 | — | — | 0.00-100.0% | 720M | |
| 9.30B+10.7% | 8.41B+18.3% | 7.11B+8.5% | 6.55B-1.7% | 6.67B+8.6% | ||
| Long-term debt | 1.99B+0.1% | 1.98B+0.1% | 1.98B+0.1% | 1.98B+0.1% | 1.98B+0.1% | |
| Deferred revenue (non-current) | 209M+12.4% | 186M+46.6% | 127M+81.5% | 69.8M-4.8% | 73.3M+26.8% | |
| Non-current lease liability | 229M+12.2% | 204M+197.1% | 68.7M+23.1% | 55.8M | — | |
| Operating lease liability (total) | 267M+13.8% | 234M+167.3% | 87.7M | — | — | |
| Finance lease liability (total) | 720M+0.0% | 720M+0.0% | 720M+0.0% | 720M+0.0% | 720M+0.3% | |
| Finance lease liability | 720M+0.0% | 720M+0.0% | 720M+0.0% | 720M | 0.00-100.0% | |
| Other non-current liabilities | 2.02B+28.5% | 1.57B+84.0% | 854M+33.9% | 638M-6.2% | 680M-1.0% | |
| 31.3B+6.5% | 29.4B+13.0% | 26.0B+14.6% | 22.7B+20.8% | 18.8B+70.2% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Additional paid-in capital | 14.0B+8.9% | 12.9B+13.2% | 11.4B+14.1% | 9.95B+23.0% | 8.09B+20.4% | |
| Retained earnings | 35.8B+13.0% | 31.7B+16.2% | 27.3B+17.0% | 23.3B+22.9% | 19.0B+74.1% | |
| Treasury stock | 18.6B+22.7% | 15.2B+20.8% | 12.6B+21.3% | 10.4B+25.3% | 8.26B+24.9% | |
| Accumulated other comprehensive income | 77.5M+1081.0% | -7.90M+90.2% | -80.9M+66.1% | -239M-811.5% | -26.2M-189.4% | |
| Total liabilities & equity | 40.6B+7.4% | 37.8B+14.1% | 33.1B+13.2% | 29.2B+14.9% | 25.4B+48.2% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 4.98B+12.6% | 4.42B-3.8% | 4.59B-8.4% | 5.01B-29.2% | 7.08B+170.5% | ||
| Depreciation & amortization | 544M+12.6% | 483M+14.7% | 421M+23.3% | 341M+19.3% | 286M+21.3% | |
| Intangible amortization | 179M+38.7% | 129M+39.8% | 92.2M+145.2% | 37.6M | 0.00 | |
| Share-based compensation | 994M+1.1% | 983M+11.1% | 885M+22.1% | 725M+20.5% | 602M+39.3% | |
| Deferred income taxes | -785M-3.7% | -757M+9.6% | -838M-12.2% | -746M-407.4% | -147M-294.6% | |
| Change in receivables | -498M-189.9% | 554M+63.5% | 339M+147.9% | -708M-136.7% | 1.93B+42.1% | |
| Change in inventory | 275M-55.6% | 620M+128.1% | 272M-61.0% | 697M+40.9% | 494M-6.6% | |
| -629M+74.5% | -2.47B+22.5% | -3.19B+15.8% | -3.78B+29.7% | -5.38B-7527.1% | ||
| Capital expenditure | 898M+18.9% | 756M+5.2% | 719M+21.8% | 590M+6.9% | 552M-10.2% | |
| Free cash flow | 4.08B+11.3% | 3.66B-5.4% | 3.88B-12.4% | 4.42B-32.2% | 6.53B+225.9% | |
| Acquisitions | 3.30M-80.0% | 16.5M-69.9% | 54.9M-76.2% | 230M | 0.00 | |
| Proceeds from sale of PP&E | 0.00-100.0% | 20.1M | 0.00 | 0.00 | — | |
| -3.72B-68.8% | -2.20B-22.9% | -1.79B-77.4% | -1.01B-0.3% | -1.01B+49.0% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 636M-56.6% | 1.47B+27.9% | 1.15B-24.6% | 1.52B-9.1% | 1.67B-35.1% | |
| Common stock repurchased | 3.44B+32.1% | 2.60B+16.5% | 2.23B+7.3% | 2.08B+26.6% | 1.65B-71.9% | |
| Dividends paid | 370M | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | -10.3M+69.2% | -33.4M | 0.00 | 0.00 | — | |
| FX effect on cash | 300K+142.9% | -700K-75.0% | -400K | 0.00 | 0.00 | |
| Net change in cash | 635M+355.1% | -249M+34.8% | -382M-272.4% | 221M-68.0% | 691M+19.7% | |
| Interest paid | 41.6M-20.9% | 52.6M-28.0% | 73.1M+36.1% | 53.7M-3.8% | 55.8M+140.5% | |
| Income taxes paid | 1.25B+68.6% | 743M-14.6% | 870M-42.1% | 1.50B+23.3% | 1.22B+547.7% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 81.6B+4.8% | 77.9B-18.6% | 95.7B+21.8% | 78.6B+14.6% | 68.5B+32.4% | |
| P/E | 18.1×+2.6% | 17.6×-26.4% | 24.0×+63.9% | 14.6×+72.4% | 8.5×-42.4% | |
| P/S | 5.7×+3.8% | 5.5×-24.9% | 7.3×+27.5% | 5.7×+34.4% | 4.3×-30.0% | |
| P/B | 2.6×-1.6% | 2.7×-31.0% | 3.8×+4.8% | 3.7×+0.4% | 3.7×-22.2% | |
| P/FCF | 20.0×-5.9% | 21.3×+2.3% | 20.8×+34.2% | 15.5×+47.5% | 10.5×-59.4% | |
| Earnings yield | 5.5%-2.6% | 5.7%+35.8% | 4.2%-39.0% | 6.8%-42.0% | 11.8%+73.6% | |
| FCF yield | 5.0%+6.3% | 4.7%-2.2% | 4.8%-25.5% | 6.5%-32.2% | 9.5%+146.1% | |
| Dividend yield | 0.44% | — | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: REGN’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all REGN filings on SEC EDGAR → Not investment advice.